ArticleBMJ nutrition, prevention & health2026
Effect of a low-carbohydrate diet on glycaemic control and disease management in type 2 diabetes: results from a prospective free-living trial.
Article in BMJ nutrition, prevention & health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Low-carbohydrate diets (LCD) improve glycaemic control (HbA1c) and weight in individuals with type 2 diabetes (T2D). Few studies have explored both the quantitative effects and qualitative experiences of individuals following LCD. Methods: Single-arm, prospective, observational study of a carbohydrate-reduced diet (CRD) on HbA1c, weight and the acceptability in people with T2D and HbA1c ≥6.5% (48 mmol/mol). Participants were recruited from general practitioner surgeries and enrolled in an eight-session CRD health coaching programme delivered by The Lifestyle Club, with follow-up over 6 months. Blood samples, anthropometric data and dietary adherence were measured at baseline and at 6 months. Participants were informed about the semi-structured interviews at consent and invited after visit 2. Results: Forty-eight participants were included (mean age 67±10 years; 55% male). Carbohydrate intake decreased from 226.0 g/day at baseline to 126.3 g/day at 6 months (p<0.001) and the proportion of energy from carbohydrates decreased from 42.6% to 29.7% (p<0.001). HbA1c decreased from 60.0±12.9 mmol/mol to 49.7±9.0 mmol/mol at 6 months (p<0.001). Mean body weight decreased by 5.2±4.4 kg (p<0.001), and body mass index decreased from 30.6±6.5 kg/m² to 28.8±5.7 kg/m² (p<0.001). No significant changes were observed in lipids or blood pressure. Regression analyses showed an association between weight loss and HbA1c normalisation (OR 1.413, p=0.002), but no relationship was found between carbohydrate intake and changes in HbA1c. Qualitative interviews revealed that motivation and empowerment were central to adherence; participants cited health improvements and reduced medication as key motivators. Challenges included social dynamics and domestic routines; older participants and those with significant comorbidities reported greater difficulties in maintaining the diet. Conclusions: CRD was associated with reduced HbA1c and weight. Weight loss was associated with HbA1c normalisation; however, no independent statistical relationship was observed between carbohydrate reduction and glycaemic outcomes. HbA1c normalisation often occurred with LCD, suggesting it is a viable option for individualised care alongside other dietary approaches in T2D.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.